WARFARIN VERSUS ASPIRIN FOR PREVENTION OF STROKE IN HEART FAILURE: A META-ANALYSIS

被引:0
|
作者
Mehta, Kathan
Grover, Peeyush
Patel, Nileshkumar J.
Shah, Neeraj
Singh, Vikas
Deshmukh, Abhishek
Marzouka, George R.
Rathod, Ankit
Savani, Ghanshyam
Chothani, Ankit
Badheka, Apurva O.
Cohen, Mauricio G.
机构
[1] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
关键词
D O I
10.1016/S0735-1097(13)60575-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E575 / E575
页数:1
相关论文
共 50 条
  • [21] Aspirin in primary prevention and the risk of heart failure: a systematic review and meta-analysis of controlled trials
    de Oliveira, Ana Beatrice Magalhaes
    Luchiari, Beatriz
    Bonilha, Isabella
    Barreto, Joaquim
    Nogueira, Ana Claudia Cavalcante
    Ceniccola, Guilherme Duprat
    Polanczyk, Carisi Anne
    Sposito, Andrei Carvalho
    de Carvalho, Luiz Sergio Fernandes
    ESC HEART FAILURE, 2023, 10 (02): : 1488 - 1491
  • [22] Warfarin versus Aspirin in Heart Failure and Sinus Rhythm REPLY
    Homma, Shunichi
    Thompson, John L. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (08): : 772 - 772
  • [23] Comparison of Direct Oral Anticoagulants and Warfarin in the Prevention of Stroke in Patients With Valvular Heart Disease: A Meta-Analysis
    Batool, Saima
    Chaudhari, Sandipkumar S.
    Shaik, Tanveer Ahamad
    Dhakal, Sandesh
    Ganaie, Zubair Ahmad
    Ghaffari, Muhammad Abu Zar
    Saleem, Faraz
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [24] Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
    Redman A.R.
    Allen L.C.
    Current Atherosclerosis Reports, 2002, 4 (4) : 319 - 325
  • [25] Mixed Treatment Comparison Meta-Analysis of Aspirin, Warfarin, and New Anticoagulants for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
    Assiri, Abdullah
    Al-Majzoub, Omar
    Kanaan, Abir O.
    Donovan, Jennifer L.
    Silva, Matthew
    CLINICAL THERAPEUTICS, 2013, 35 (07) : 967 - 984
  • [26] Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis
    Lip, Gregory Y. H.
    Edwards, Steven J.
    THROMBOSIS RESEARCH, 2006, 118 (03) : 321 - 333
  • [27] Aspirin and dipyridamole used in combination versus thienopyridines for the prevention of stroke and serious vascular events: A meta-analysis
    Sud, Sachin
    Sud, Maneesh
    Krahn, Andrew
    Massel, David
    STROKE, 2007, 38 (02) : 525 - 525
  • [28] Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: Subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study
    Sacco, Ralph L.
    Prabhakaran, Shyam
    Thompson, J. L. P.
    Murphy, Amy
    Sciacca, Robert R.
    Levin, Bruce
    Mohr, J. P.
    CEREBROVASCULAR DISEASES, 2006, 22 (01) : 4 - 12
  • [29] Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial
    Pullicino, Patrick M.
    Thompson, John L. P.
    Sacco, Ralph L.
    Sanford, Alexandra R.
    Qian, Min
    Teerlink, John R.
    Haddad, Haissam
    Diek, Monika
    Freudenberger, Ronald S.
    Labovitz, Arthur J.
    Di Tullio, Marco R.
    Lok, Dirk J.
    Ponikowski, Piotr
    Anker, Stefan D.
    Graham, Susan
    Mann, Douglas L.
    Mohr, J. P.
    Homma, Shunichi
    CEREBROVASCULAR DISEASES, 2013, 36 (01) : 74 - 78
  • [30] Warfarin and aspirin for primary prevention in patients with heart failure in sinus rhythm
    Conti, Margherita
    Trippoli, Sabrina
    Messori, Andrea
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2013, 3 (02) : 111 - 112